John Overdeck’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

John Overdeck’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$817K	Buy	+24,100	New	+$803K	﹤0.01%	3767
2026 Q1	–	Sell	-23,000	Closed	-$718K	–	4921
2025 Q4	$718K	Buy	+23,000	New	+$567K	﹤0.01%	3121
2021 Q4	–	Sell	-170,000	Closed	-$1.66M	–	4882
2021 Q3	$1.66M	Buy	170,000 +124,400	+273%	+$1.16M	﹤0.01%	2159
2021 Q2	$451K	Sell	45,600 -15,700	-26%	-$166K	﹤0.01%	3192
2021 Q1	$707K	Buy	+61,300	New	+$703K	﹤0.01%	2624
2020 Q4	–	Sell	-25,300	Closed	-$228K	–	3757
2020 Q3	$228K	Sell	25,300 -11,500	-31%	-$122K	﹤0.01%	2746
2020 Q2	$454K	Sell	36,800 -56,400	-61%	-$638K	﹤0.01%	2066
2020 Q1	$837K	Sell	93,200 -449,300	-83%	-$4.6M	0.01%	1550
2019 Q4	$5.32M	Buy	542,500 +466,300	+612%	+$4.16M	0.02%	915
2019 Q3	$524K	Sell	76,200 -76,700	-50%	-$588K	﹤0.01%	2520
2019 Q2	$1.41M	Buy	152,900 +123,700	+424%	+$1.49M	﹤0.01%	1674
2019 Q1	$458K	Buy	+29,200	New	+$515K	﹤0.01%	2320
2018 Q4	–	Sell	-62,900	Closed	-$1.36M	–	3516
2018 Q3	$1.36M	Sell	62,900 -21,400	-25%	-$497K	﹤0.01%	1763
2018 Q2	$2.05M	Sell	84,300 -146,400	-63%	-$2.99M	0.01%	1598
2018 Q1	$3.94M	Buy	230,700 +155,100	+205%	+$3.03M	0.01%	1090
2017 Q4	$1.43M	Buy	75,600 +59,200	+361%	+$891K	﹤0.01%	1713
2017 Q3	$289K	Sell	16,400 -29,600	-64%	-$666K	﹤0.01%	2434
2017 Q2	$1.53M	Sell	46,000 -94,400	-67%	-$2.92M	0.01%	1605
2017 Q1	$4.5M	Buy	+140,400	New	+$4.79M	0.02%	982
2016 Q4	–	Sell	-152,700	Closed	-$7.03M	–	3507
2016 Q3	$7.03M	Buy	152,700 +146,700	+2,445%	+$7.65M	0.03%	708
2016 Q2	$301K	Hold	6,000	–	–	﹤0.01%	2558
2016 Q1	$321K	Buy	6,000 +1,900	+46%	+$111K	﹤0.01%	2347
2015 Q4	$269K	Buy	+4,100	New	+$253K	﹤0.01%	2308

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

John Overdeck's TEVA Position: Q2 2026 in Review

John Overdeck reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 37% in Q2 2026, selling an estimated $4.51M and leaving 231,287 shares worth $7.84M. The position accounts for 0.01% of the portfolio, ranked #1717.

John Overdeck first reported a position in TEVA in Q2 2013 and has held it in 49 quarters since. The position peaked at $142M in Q4 2016. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

John Overdeck held 231,287 shares of Teva Pharmaceutical Industries Limited worth $7.84M as of Q2 2026.
John Overdeck sold 135,504 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $4.51M.
Teva Pharmaceutical Industries Limited made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1717 holding.
John Overdeck first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 49 quarters since.
John Overdeck's Teva Pharmaceutical Industries Limited position peaked at $142M in Q4 2016.
677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.